Editorial: Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond

被引：5
|
作者：
Grandi, Eleonora [1 ]
Morotti, Stefano [1 ]
Pueyo, Esther [2 ]
Rodriguez, Blanca [3 ]
机构：
[1] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA
[2] Univ Zaragoza, Aragon Inst Engn Res, Biomed Signal Interpretat & Computat Simulat Grp, IIS Aragon, Zaragoza, Spain
[3] Univ Oxford, Dept Comp Sci, Oxford, England
来源：
FRONTIERS IN PHYSIOLOGY | 2018年 / 9卷
基金：
英国惠康基金;
关键词：
cardiotoxicity; QT interval prolongation; drug-induced arrhythmia; multi-scale modeling; cardiac electrophysiology; TORSADES-DE-POINTES; TRANSMURAL DISPERSION; MODELS; REPOLARIZATION; DRUGS; ELECTROPHYSIOLOGY; CONVERGENCE; SIMULATION; PREDICTION; DYNAMICS;
D O I：
10.3389/fphys.2018.00678
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Safety pharmacology and prolongation of the QT interval
    Cavero, Icilio
    Yan, Gan-Xin
    Lux, Robert
    Steinhoff, Uwe
    JOURNAL OF ELECTROCARDIOLOGY, 2007, 40 (01) : S58 - S61
  • [2] QT interval prolongation and beyond
    Couderc, Jean-Philippe
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2006, 11 (04) : 287 - 288
  • [3] The preclinical assessment of the risk for QT interval prolongation
    Champeroux, P
    Martel, E
    Vannier, C
    Blanc, V
    Leguennec, JY
    Fowler, J
    Richard, S
    THERAPIE, 2000, 55 (01): : 101 - 109
  • [4] QT PRODACT: Usability of miniature pigs in safety pharmacology studies: Assessment for drug-induced QT interval prolongation
    Kano, M
    Toyoshi, T
    Iwasaki, S
    Kato, M
    Shimizu, M
    Ota, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 99 (05) : 501 - 511
  • [5] Drug induced QT interval prolongation and safety pharmacology studies/ICH strategy
    Fujimori, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 21P - 21P
  • [6] Effects of nortriptyline on QT prolongation: A safety pharmacology study
    Jeon, Seol-Hee
    Jaekal, Jun
    Lee, Seung Ho
    Choi, Bok-Hee
    Kim, Ki-Suk
    Jeong, Ho-Sang
    Han, Soon Young
    Kim, Eun-Jung
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2011, 30 (10) : 1649 - 1656
  • [7] MEASUREMENT OF THE QT INTERVAL AND THE RISK ASSOCIATED WITH QT(C) INTERVAL PROLONGATION - A REVIEW
    MOSS, AJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (06): : B23 - B25
  • [8] Multifactorial QT Interval Prolongation: The Risk of Polypharmacy
    Digby, G.
    Perez Riera, A. R.
    Barros, R. B.
    de Sousa Belem, L.
    Fong, C.
    Methot, M.
    Femenia, F.
    Baranchuk, A.
    NEW HORIZONS IN CARDIOVASCULAR DISEASES, 2010, : 241 - 244
  • [9] Reconciling the risk of QT interval prolongation in antidepressants
    McKean, Alastair J.
    Sola, Christopher L.
    Galardy, Christine
    Kung, Simon
    Lineberry, Timothy W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (03) : 329 - 330
  • [10] MULTIFACTORIAL QT INTERVAL PROLONGATION: THE RISK OF POLYPHARMACY
    Digby, G. C.
    Riera, A. R.
    Barros, R. B.
    Belem, L. S.
    Fong, C.
    Methot, M.
    Femenia, F.
    Baranchuk, A. M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 132D - 132D
12345